Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT04897685 |
Other study ID # |
JAMKUAS |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
January 1, 2019 |
Est. completion date |
March 31, 2021 |
Study information
Verified date |
June 2021 |
Source |
JAMK University Of Applied Sciences |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
This multi-centre research investigates the effects of nature-based treatment group on
participants diagnosed with depression. In total, 147 persons participated in the study in
various locations in Finland. All participants received treatment as usual (TAU). They were
randomised into nature-based group + TAU (n = 70) or TAU-only (n = 77). The participants in
the nature-based group + TAU were offered 12 sessions once a week in addition to standard
care. The measurement points included pre-treatment measurement at the baseline and
post-treatment measurement at the end of the intervention, which was 12 weeks after the
pre-treatment measurement. The follow-up measurement was 3 months after the post-treatment
measurement. The effects of the intervention were assessed with a clinical measure of
depression (BDI-I) and with indicators of psychological distress (CORE-10), subjective
well-being (SWEMWBS), work/study ability (WAI) and nature experiences (ROS, KOLU). The
participants in the treatment group (nature-based group +TAU) were compared to the
participants in the control group who received TAU-only.
Description:
This research investigates the outcomes of nature-based treatment groups in the treatment of
adults with depression. In total, 147 participants were involved. Of them, 70 were randomized
into DMT group and 77 into the control group. All participants received treatment as usual
during the research. The inclusion criteria of the study were: a diagnoses of depression (ICD
-diagnostic system), BDI-I score 10 or above (cut off score for mild depression), treatment
contact in a health care service and 18-65 years of age. The exclusion criteria were: 1)
active suicidal ideation, 2) psychotic symptoms, and 3) substance misuse that is on a
critical level (Audit questionnaire scores above 10). Also, participants who had pain-related
problems that restricted daily life or were pregnant were not admitted to the study.
Nature-based treatment group was facilitated by a health care professional and included 12 x
90 mins sessions within 12 weeks. Depressive symptoms (BDI-I), psychological distress
(CORE-10), subjective well-being (SWEMWBS), ability to work/study (WAI), and nature
experiences (ROS, KOLU) were assessed at three measurement points: pre-measurement at the
baseline, post-measurement 12 weeks after the pre-treatment measurement, and a follow-up
measurement three months after the post-treatment measurement.
This research includes a larger number of participants (N = 147) than have been involved in
previous studies utilising randomised controlled trials in nature-based interventions. The
research generates further information about the effectiveness of nature-based therapy groups
in the rehabilitation of depression as it was conducted in five cities across Finland. This
type of multi-centre research can provide a realistic picture of the typical practice of a
range of health care professionals working with participants in various geographic locations.